Navigation Links
Access Pharmaceuticals Announces European License Agreement With Norgine
Date:8/7/2014

ent and supportive care of cancer patients. Access' products include MuGard™ (www.MuGard.com), which has received FDA-marketing clearance for the management of patients with mucositis, and ProLindac™, a second generation DACH platinum drug. The Company also has other advanced drug delivery technologies including CobaCyte™-mediated targeted delivery and CobOral-oral drug delivery, its proprietary nanopolymer delivery technology based on the natural vitamin B12 uptake mechanism.  For additional information on Access Pharmaceuticals, please visit our website at www.accesspharma.com.

This press release contains certain statements that are forward-looking within the meaning of Section 27a of the Securities Act of 1933, as amended, and that involve risks and uncertainties. These statements include those relating to: our cash burn rate, clinical trial plans and timelines and clinical results for ProLindac, MuGard and Cobalamin, our ability to achieve clinical and commercial success and our ability to successfully develop marketed products. These statements are subject to numerous risks, including but not limited to Access' need to obtain additional financing in order to continue the clinical trial and operations and to the risks detailed in Access' Annual Reports on Form 10-K and other reports filed by Access with the Securities and Exchange Commission.

Company and Media Contact:
Christine Berni
Director of Investor Relations
Access Pharmaceuticals, Inc.
(212) 786-6208


'/>"/>
SOURCE Access Pharmaceuticals, Inc.
Copyright©2014 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. MedVantx Announces End of Runway Pharmacy to Offer Enhanced Specialty Pharmacy and Direct-to-Patient Medication Access Services
2. IRIDEX to Present at 2014 Wedbush Life Sciences Management Access Conference
3. Xencor to Present at Wedbush Securities 2014 Life Sciences Management Access Conference
4. Cardica To Present At 2014 Wedbush PacGrow Life Sciences Management Access Conference
5. TB Alliance Names Elana Robertson Senior Vice President, Market Access
6. Access Pharmaceuticals Featured On OncLive.com
7. McGraw-Hill Education Professionals AccessMedicine App Delivers Instant Access to Essential Diagnostic Tools
8. Healthcare Sciences Publisher PLM and IBM Speed Access to Medical Information to Deliver Better Patient Care with Mobile
9. Patients Join to Fight Major Cuts in Prescription Coverage Says Patients and Physicians for Rx Access
10. Improving quality and access to advanced cancer care in India and South Asia
11. ideaPoint, Inc. Announces Launch of Multi-Sponsor Portal Providing Researchers Opportunity to Request Access to Clinical Data from Five Global Study Sponsors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2015)... -- Xencor, Inc. (NASDAQ: XNCR ), a clinical-stage ... treatment of autoimmune diseases, asthma and allergic diseases, ... first quarter ended March 31, 2015 and provided a ... equity offering in February, which raised net proceeds ... strong financial position to advance our lead pipeline ...
(Date:5/4/2015)... 4, 2015 PTC Therapeutics, Inc. (NASDAQ: PTCT ... for the first quarter ending March 31, 2015. ... In our first full quarter since the commercial launch, we ... treatment for nonsense mutation Duchene Muscular Dystrophy. We now have ... treatment since our last earnings call," stated Stuart W. ...
(Date:5/4/2015)... Pa. , May 4, 2015 DePuy ... Dura Repair, the first commercially available biosynthesized dural ... Synthes CMF is a part of the DePuy Synthes ... is a tissue membrane that covers and protects the ... be cut to allow surgeons to access the brain. ...
Breaking Medicine Technology:Xencor Reports First Quarter 2015 Financial and Operating Results 2Xencor Reports First Quarter 2015 Financial and Operating Results 3Xencor Reports First Quarter 2015 Financial and Operating Results 4Xencor Reports First Quarter 2015 Financial and Operating Results 5Xencor Reports First Quarter 2015 Financial and Operating Results 6Xencor Reports First Quarter 2015 Financial and Operating Results 7Xencor Reports First Quarter 2015 Financial and Operating Results 8PTC Therapeutics Reports First Quarter 2015 Financial Results and Provides Corporate Update 2PTC Therapeutics Reports First Quarter 2015 Financial Results and Provides Corporate Update 3PTC Therapeutics Reports First Quarter 2015 Financial Results and Provides Corporate Update 4PTC Therapeutics Reports First Quarter 2015 Financial Results and Provides Corporate Update 5PTC Therapeutics Reports First Quarter 2015 Financial Results and Provides Corporate Update 6PTC Therapeutics Reports First Quarter 2015 Financial Results and Provides Corporate Update 7PTC Therapeutics Reports First Quarter 2015 Financial Results and Provides Corporate Update 8PTC Therapeutics Reports First Quarter 2015 Financial Results and Provides Corporate Update 9DePuy Synthes CMF Launches First Biosynthesized Cellulose-Based Dural Replacement For Neurosurgery 2DePuy Synthes CMF Launches First Biosynthesized Cellulose-Based Dural Replacement For Neurosurgery 3
... 6, 2012  Genomic Health, Inc. (Nasdaq: GHDX ) ... the goal of improving the quality of diagnosis, communication and ... common and rare genetic conditions.   The subsidiary is expected to ... commercial service in 2013.  The new venture will be led ...
... (LSE: SN, NYSE: SNN ), the global ... subsidiary, Smith & Nephew, Inc., have reached settlements with ... Department of Justice (DOJ) in connection with their Foreign ... Smith & Nephew has committed to pay $22,226,799 in ...
Cached Medicine Technology:Genomic Health Announces Formation of New Genetics Subsidiary 2Genomic Health Announces Formation of New Genetics Subsidiary 3Genomic Health Announces Formation of New Genetics Subsidiary 4Smith & Nephew Reaches Settlement With US Government 2Smith & Nephew Reaches Settlement With US Government 3
(Date:5/4/2015)... The University of California, Davis and ... initiative at UC Davis School of Medicine dedicated ... to advancing Latino health. , The program, called ... to Be Physicians, (“Prep Médico” for short) is ... and internship opportunities, a residential program, intensive language ...
(Date:5/4/2015)... New York, NY (PRWEB) May 04, 2015 ... in specialized insurance programs, announces the expansion of coverage ... ESIP is a leading provider of industry-tailored insurance and ... “At McNeil & Company, we are dedicated to providing ... coverage to meet their many evolving needs. We are ...
(Date:5/4/2015)... (PRWEB) May 04, 2015 TROY Healthcare ... Cerner North Atlantic Regional User Group (RUG) Conference in ... Cerner North Atlantic Regional User Group provides an opportunity ... and explore the exhibitor gallery. , In addition to ... at the Cerner North Atlantic RUG Conference. Attendees can ...
(Date:5/4/2015)... 04, 2015 Baptist Medical Center ... Association’s Get With The Guidelines®-Stroke Gold Plus Quality ... Roll. The award recognizes the hospital’s commitment and ... most appropriate treatment according to nationally recognized, research-based ... To receive the Gold Plus Quality Achievement Award, ...
(Date:5/4/2015)... Now in its seventh year, the ... have made outstanding contributions to the company, to their ... acute and post-acute care settings. The five award categories ... the Year, Advanced Practice Clinician of the Year, Newcomer ... Year. Recipients are selected by IPC’s senior management team. ...
Breaking Medicine News(10 mins):Health News:New UC Davis Program Targets Next Generation of Physicians to Advance Latino Health 2Health News:New UC Davis Program Targets Next Generation of Physicians to Advance Latino Health 3Health News:New UC Davis Program Targets Next Generation of Physicians to Advance Latino Health 4Health News:New UC Davis Program Targets Next Generation of Physicians to Advance Latino Health 5Health News:Insurance Leader McNeil & Company Expands Coverage for Emergency Services Insurance Program (ESIP), Launches Enhancements to Property and Casualty Insurance Package 2Health News:Insurance Leader McNeil & Company Expands Coverage for Emergency Services Insurance Program (ESIP), Launches Enhancements to Property and Casualty Insurance Package 3Health News:TROY Healthcare to Exhibit at the Cerner North Atlantic Regional User Group Conference 2Health News:TROY Healthcare to Exhibit at the Cerner North Atlantic Regional User Group Conference 3Health News:Baptist Medical Center Jacksonville Receives Top Honor for Stroke Care 2Health News:Baptist Medical Center Jacksonville Receives Top Honor for Stroke Care 3Health News:Baptist Medical Center Jacksonville Receives Top Honor for Stroke Care 4Health News:IPC Healthcare Announces Clinicians of the Year 2Health News:IPC Healthcare Announces Clinicians of the Year 3
... Registration, Evaluation and Authorization of Chemicals, has shifted the burden ... ,The chemical companies would be bound by law to ... business. ,This law aims to make chemicals used ... users and the environs. ,The European Parliament has ...
... of three doctors on an indefinite hunger strike here ... deteriorated Sunday.// ,The three are under observation ... of the All India Institute of Medical Sciences (AIIMS) ... a bill favouring quotas. ,"Their condition has ...
... the National Surgical Adjuvant Breast and Bowel Project ... Antonio Breast Cancer Symposium, showed that// postmenopausal women ... after five years of tamoxifen were 56% less ... than those who received placebo (P=0.004). ...
... slow the loss of central vision has shown promise ... which involves the same central// light-sensitive area of retina, ... ,Encouraged by the effect of ranibuzumab in people ... into the eyes of 10 people losing their sight ...
... certain types of inhaled particles in occupational settings and ... lung cancer risk. The December// Journal of Occupational and ... Occupational and Environmental Medicine (ACOEM), is a special issue ... remarkable consistency exists among many types of studies for ...
... for ovarian cancer are at increased risk of a ... have high// levels of a binding protein that triggers ... of malignancy. ,“Now there’s the possibility that ... surgery might identify women most at risk for recurrence ...
Cached Medicine News:Health News:New Study Shows Efficacy of AROMASIN on Early Breast Cancer 2Health News:New Study Shows Efficacy of AROMASIN on Early Breast Cancer 3Health News:New Study Shows Efficacy of AROMASIN on Early Breast Cancer 4Health News:Drug Treatment Slows Macular Vision Loss in Diabetics 2Health News:Inhaled Particles Increases the Risk of Lung Cancer 2Health News:'Clumping' Protein Linked to Return of Ovarian Cancer 2
Exo-Deluxe Overhead Traction for hospital or home care. Twice the clearance of other units between the patient and supporting wall. 2" nylon pulleys with polypropylene cord, head halter, spreader bar...
Wonderflex™ is a lined soft durometer silicone gel sheet. It is ideal for cushioning orthotic/prosthetic devices and offers protection from shock and sheer forces. Wonderflex can also be lamina...
Designed to provide relief from chronic or acute back pain by unloading pressure off the lumbar discs and shifting pressure to the abdominal region...
Effectively stabilize and relax your back with the LumboTrain back support....
Medicine Products: